Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
BMC Pediatrics|March 9, 2021
Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
Research Square|July 29, 2026
Prenatal methylmercury exposure disrupts developmental trajectories and induces sex-specific toxicity in pubertal ratsJessica L Bradshaw, E Nicole Wilson, Steve Mabry, et al.
Radiology|May 20, 2015
Radiation Doses in Consecutive CT Examinations from Five University of California Medical CentersRebecca Smith-Bindman, Michelle Moghadassi, Nicole Wilson, et al.
Endocrinology|September 1, 2021
Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative StressNathalie Sumien, J Thomas Cunningham, Delaney L Davis, et al.
American Journal of Physiology. Cell Physiology|July 21, 2025
Gestational chronic intermittent hypoxia triggers maternal inflammation and disrupts placental stress responsesJennifer J Gardner, Reneé de Nazaré Oliveira da Silva, Jessica L Bradshaw, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Gestational Chronic Intermittent Hypoxia Triggers Maternal Inflammation and Disrupts Placental Stress ResponsesJennifer J Gardner, Reneé de Nazaré Oliveira da Silva, Jessica L Bradshaw, et al.
Elife|April 19, 2021
DCC regulates astroglial development essential for telencephalic morphogenesis and corpus callosum formationLaura Morcom, Ilan Gobius, Ashley Pl Marsh, et al.
Vaccine: X|March 8, 2021
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAmanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, et al.
BMJ Open|May 26, 2020
10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trialVictor M Oguoma, Nicole Wilson, Kim Mulholland, et al.
Human Mutation|October 26, 2017
DCC mutation update: Congenital mirror movements, isolated agenesis of the corpus callosum, and developmental split brain syndromeAshley P L Marsh, Timothy J Edwards, Charles Galea, et al.
Pageof 19